Jubilant Clinsys

Jubilant Clinsys was a global Contract Research Organization (CRO) providing a comprehensive suite of clinical development services to the pharmaceutical, biotechnology, and medical device industries. As a subsidiary of Jubilant Life Sciences, the company specialized in Phase I-IV clinical trials, offering expertise in study design, project management, clinical data management, and regulatory affairs. It operated significant facilities in both the United States and India, positioning itself as a cost-effective partner for end-to-end drug development. In 2019, the company's operations were integrated into Jubilant Biosys to create a unified "Discovery to Development" service platform. This restructuring aimed to streamline the parent company's research and development offerings under a single organizational umbrella.